Literature DB >> 30025098

Surgical Removal of Internal Limiting Membrane and Layering of AAV Vector on the Retina Under Air Enhances Gene Transfection in a Nonhuman Primate.

Kelvin Yi Chong Teo1,2, Shu Yen Lee1,2, Amutha Veluchamy Barathi3,4, Sai Bo Bo Tun3, Licia Tan1,2, Ian Jeffery Constable5,6.   

Abstract

Purpose: To determine if the surgical removal of the internal limiting membrane (ILM) in nonhuman primates (NHPs) will result in safe and effective transfection of adeno-associated viral (AAV2) vectors using green fluorescent protein (GFP) as a reporter.
Methods: Six Macaca fascicularis NHP eyes underwent vitrectomy, ILM peel with layering of 1.7 × 1013 genome copies per milliliter of AAV2-GFP under air. Four control eyes underwent only vitrectomy and pooling under air. The intensity and area transfected was quantified in vivo with fundus autofluorescence (FAF) imaging. NHPs were euthanized 16 weeks postsurgery and immunohistochemical analysis assessed GFP expression at the cellular level.
Results: There was a larger area of fluorescence in ILM peeled eyes then in non-ILM peeled eyes (50.7 [33.1-58.4] pixel2 versus 5.1 [0.6-7.6] pixel2, P < 0.01). The intensity of fluorescence was also higher in ILM peeled eyes (10.3 [2.2-18.5] vs. 1.9 [0.6-4.4], P = 0.05). Non-ILM peeled eyes displayed fluorescence confined to the foveal center. Histological sections showed colocalization in the Müller cell layer, ganglion cell layer, and photoreceptor cell layer in the ILM peeled eyes. In non-ILM peeled eyes GFP expression was only in the ganglion cell layer in three eyes and was confined to the immediate vicinity of the fovea. Conclusions: ILM appears to be the predominate barrier to AAV transfection. An efficacious and safe method of AAV2 gene delivery, taking into account the potential need for repeat treatments, appears to be the surgical removal of ILM and layering of AAV under air.v.

Entities:  

Mesh:

Year:  2018        PMID: 30025098     DOI: 10.1167/iovs.18-24333

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease.

Authors:  Sophia-Martha Kleine Holthaus; Mikel Aristorena; Ryea Maswood; Olha Semenyuk; Justin Hoke; Aura Hare; Alexander J Smith; Sara E Mole; Robin R Ali
Journal:  Hum Gene Ther       Date:  2020-07       Impact factor: 5.695

2.  Fundus imaging of retinal ganglion cells transduced by retrograde transport of rAAV2-retro.

Authors:  Rakesh Nanjappa; Mikayla D Dilbeck; John R Economides; Jonathan C Horton
Journal:  Exp Eye Res       Date:  2022-04-20       Impact factor: 3.770

Review 3.  The internal limiting membrane: Roles in retinal development and implications for emerging ocular therapies.

Authors:  Kevin Y Zhang; Thomas V Johnson
Journal:  Exp Eye Res       Date:  2021-03-20       Impact factor: 3.467

Review 4.  Delivering AAV to the Central Nervous and Sensory Systems.

Authors:  Cole W Peters; Casey A Maguire; Killian S Hanlon
Journal:  Trends Pharmacol Sci       Date:  2021-04-13       Impact factor: 17.638

5.  Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates.

Authors:  Glenn Yiu; Sook Hyun Chung; Iris N Mollhoff; Uyen Tu Nguyen; Sara M Thomasy; Jesse Yoo; Donna Taraborelli; Glenn Noronha
Journal:  Mol Ther Methods Clin Dev       Date:  2020-01-21       Impact factor: 6.698

Review 6.  Advances in Ophthalmic Optogenetics: Approaches and Applications.

Authors:  Philipp P Prosseda; Matthew Tran; Tia Kowal; Biao Wang; Yang Sun
Journal:  Biomolecules       Date:  2022-02-08

7.  Role of the Internal Limiting Membrane in Structural Engraftment and Topographic Spacing of Transplanted Human Stem Cell-Derived Retinal Ganglion Cells.

Authors:  Kevin Y Zhang; Caitlyn Tuffy; Joseph L Mertz; Sarah Quillen; Laurence Wechsler; Harry A Quigley; Donald J Zack; Thomas V Johnson
Journal:  Stem Cell Reports       Date:  2020-12-30       Impact factor: 7.765

Review 8.  Gene-Based Therapeutics for Inherited Retinal Diseases.

Authors:  Beau J Fenner; Tien-En Tan; Amutha Veluchamy Barathi; Sai Bo Bo Tun; Sia Wey Yeo; Andrew S H Tsai; Shu Yen Lee; Chui Ming Gemmy Cheung; Choi Mun Chan; Jodhbir S Mehta; Kelvin Y C Teo
Journal:  Front Genet       Date:  2022-01-07       Impact factor: 4.599

Review 9.  Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and Progress.

Authors:  Tien-En Tan; Beau James Fenner; Veluchamy Amutha Barathi; Sai Bo Bo Tun; Yeo Sia Wey; Andrew Shih Hsiang Tsai; Xinyi Su; Shu Yen Lee; Chui Ming Gemmy Cheung; Tien Yin Wong; Jodhbir Singh Mehta; Kelvin Yi Chong Teo
Journal:  Front Genet       Date:  2021-12-07       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.